S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TNGX Tango Therapeutics Inc

3.20

-0.27 (-7.78%)

Last Updated: 05:23:22

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Tango Therapeutics Charts.

Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Tango Therapeutics Charts.

Tango Therapeutics Inc News

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 2 January 2025 (6 days ago) • Edgar (US Regulatory)

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 3 December 2024 (1 month ago) • Business Wire

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Wednesday 27 November 2024 (1 month ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Wednesday 6 November 2024 (2 months ago) • Business Wire

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
Wednesday 6 November 2024 (2 months ago) • Business Wire

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

More Tango Therapeutics Inc News Articles

Australian SE All Ordina...

Commonwealth Bank Of Aus...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions